BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32349929)

  • 1. Procarcinogen Activation and Mutational Signatures Model the Initiation of Carcinogenesis in Human Urothelial Tissues In Vitro.
    Baker SC; Mason AS; Southgate J
    Eur Urol; 2020 Aug; 78(2):143-147. PubMed ID: 32349929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients.
    Fantini D; Seiler R; Meeks JJ
    Urol Oncol; 2019 Nov; 37(11):818-825. PubMed ID: 30446446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of "luminal" muscle-invasive bladder cancers.
    Baker SC; Arlt VM; Indra R; Joel M; Stiborová M; Eardley I; Ahmad N; Otto W; Burger M; Rubenwolf P; Phillips DH; Southgate J
    Mol Carcinog; 2018 May; 57(5):606-618. PubMed ID: 29323757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational signatures efficiently identify different mutational processes underlying cancers with similar somatic mutation spectra.
    Zhou N; Yuan Y; Long X; Wu C; Bao J
    Mutat Res; 2017 Dec; 806():27-30. PubMed ID: 28942182
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Weyerer V; Eckstein M; Strissel PL; Wullweber A; Lange F; Tögel L; Geppert CI; Sikic D; Taubert H; Wach S; Wullich B; Hartmann A; Stoehr R; Giedl J
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
    Phillips DH
    DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors.
    Koutros S; Rao N; Moore LE; Nickerson ML; Lee D; Zhu B; Pardo LA; Baris D; Schwenn M; Johnson A; Jones K; Garcia-Closas M; Prokunina-Olsson L; Silverman DT; Rothman N; Dean M
    Clin Cancer Res; 2021 Jul; 27(13):3725-3733. PubMed ID: 33849962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental models of human bladder carcinogenesis.
    Crallan RA; Georgopoulos NT; Southgate J
    Carcinogenesis; 2006 Mar; 27(3):374-81. PubMed ID: 16287878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of urothelial carcinoma.
    Miyazaki J; Nishiyama H
    Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.
    Otto W; Denzinger S; Bertz S; Gaumann A; Wild PJ; Hartmann A; Stoehr R
    Int J Cancer; 2009 Nov; 125(9):2205-8. PubMed ID: 19621447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
    Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive heterogeneity in somatic mutation and selection in the human bladder.
    Lawson ARJ; Abascal F; Coorens THH; Hooks Y; O'Neill L; Latimer C; Raine K; Sanders MA; Warren AY; Mahbubani KTA; Bareham B; Butler TM; Harvey LMR; Cagan A; Menzies A; Moore L; Colquhoun AJ; Turner W; Thomas B; Gnanapragasam V; Williams N; Rassl DM; Vöhringer H; Zumalave S; Nangalia J; Tubío JMC; Gerstung M; Saeb-Parsy K; Stratton MR; Campbell PJ; Mitchell TJ; Martincorena I
    Science; 2020 Oct; 370(6512):75-82. PubMed ID: 33004514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.
    Poon SL; Pang ST; McPherson JR; Yu W; Huang KK; Guan P; Weng WH; Siew EY; Liu Y; Heng HL; Chong SC; Gan A; Tay ST; Lim WK; Cutcutache I; Huang D; Ler LD; Nairismägi ML; Lee MH; Chang YH; Yu KJ; Chan-On W; Li BK; Yuan YF; Qian CN; Ng KF; Wu CF; Hsu CL; Bunte RM; Stratton MR; Futreal PA; Sung WK; Chuang CK; Ong CK; Rozen SG; Tan P; Teh BT
    Sci Transl Med; 2013 Aug; 5(197):197ra101. PubMed ID: 23926199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.
    Kim J; Mouw KW; Polak P; Braunstein LZ; Kamburov A; Kwiatkowski DJ; Rosenberg JE; Van Allen EM; D'Andrea A; Getz G
    Nat Genet; 2016 Jun; 48(6):600-606. PubMed ID: 27111033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of time dependence and interindividual differences in benzo[a]pyrene-mediated CYP1A1 induction and genotoxicity in porcine urinary bladder cell cultures.
    Plottner S; Borza A; Wolf A; Bolt HM; Kuhlmann J; Follmann W
    J Toxicol Environ Health A; 2008; 71(13-14):969-75. PubMed ID: 18569604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of Cancer Mutational Signatures with Individual Components of Cigarette Smoking.
    Mingard C; Battey JND; Takhaveev V; Blatter K; Hürlimann V; Sierro N; Ivanov NV; Sturla SJ
    Chem Res Toxicol; 2023 Apr; 36(4):714-723. PubMed ID: 36976926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.